The pooling analysis also revealed that TGR5 is highly expressed in lymphoma, leukemia, colorectal cancer, gastric cancer, lung cancer, prostate cancer, brain cancer, breast cancer, kidney cancer, ovarian cancer, cervical cancer, sarcoma (SARC), liver cancer, and melanoma (Supplement Figures S12 and S13). Here, GPBAR1 is linked to prostate carcinoma.